Nobilamides A-H, Long-Acting Transient Receptor Potential Vanilloid-1 (TRPV1) Antagonists from Mollusk-Associated Bacteria

被引:32
|
作者
Lin, Zhenjian [1 ]
Reilly, Christopher A. [2 ]
Antemano, Rowena [4 ]
Hughen, Ronald W. [3 ]
Marett, Lenny [1 ]
Concepcion, Gisela P. [4 ]
Haygood, Margo G. [5 ]
Olivera, Baldomero M. [6 ]
Light, Alan [3 ]
Schmidt, Eric W. [1 ,6 ]
机构
[1] Univ Utah, Dept Med Chem, Salt Lake City, UT 84112 USA
[2] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA
[3] Univ Utah, Dept Anesthesiol, Salt Lake City, UT 84112 USA
[4] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines
[5] Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Environm & Biomol Syst, Beaverton, OR 97006 USA
[6] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA
关键词
CAPSAICIN RECEPTOR; ION-CHANNEL; CELL-DEATH; EPITHELIAL-CELLS; ACTIVATION; SENSITIZE; CYSTEINE; TL-119; ACIDS;
D O I
10.1021/jm101621u
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
New compounds nobilamides A-H and related known compounds A-3302-A and A-3302-B were isolated based upon their suppression of capsaicin-induced calcium uptake in a mouse dorsal root ganglion primary cell culture assay. Two of these compounds, nobilamide B and A-3302-A, were shown to be long-acting antagonists of mouse and human TRPV1 channels, abolishing activity for >1 h after removal of drug presumably via a covalent attachment. Other derivatives also inhibited the TRPV1 channel, albeit with low potency, affording a structure-activity profile to support the proposed mechanism of action. While the activities were modest, we propose a new mechanism of action and a new site of binding for these inhibitors that may spur development of related analogues for treatment of pain.
引用
收藏
页码:3746 / 3755
页数:10
相关论文
共 50 条
  • [1] The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor
    Holzer, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (08) : 1145 - 1162
  • [2] Transient receptor potential vanilloid-1 (TRPV1) channels act as suppressors of the growth of glioma
    Cheng, Jingjing
    Zeng, Mengliu
    Peng, Biwen
    Li, Ping
    Zhao, Shiyu
    BRAIN RESEARCH BULLETIN, 2024, 211
  • [3] Bronchopulmonary actions of transient receptor potential vanilloid-1 (TRPV1) agonists in guinea pigs
    Stengel, P. W.
    Calligaro, D. O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [4] Transient receptor potential vanilloid-1 (TRPV1) in herpes zoster: Its expression and potential significance
    Han, Sang Bum
    Jun, Hee Jin
    Cho, Sang Hyun
    Lee, Jeong Deuk
    Chung, Jin Ho
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB142 - AB142
  • [5] Rat transient receptor potential vanilloid-1 (TRPV1), but not human TRPV1, releases intracellular calcium from thapsigargin sensitive stores
    Sadofsky, LR
    Compton, SJ
    Morice, AH
    FASEB JOURNAL, 2005, 19 (05): : A1092 - A1092
  • [6] Immunohistochemical localization of transient receptor potential vanilloid-1 (TRPV1) in rat stomach: Relationship to neuropeptides
    Horie, S
    Michael, GJ
    Priestley, JV
    JOURNAL OF NEUROCHEMISTRY, 2005, 94 : 184 - 184
  • [7] Activation of the transient receptor potential vanilloid-1 (TRPV1) channel opens the gate for pain relief
    Jancso, G.
    Dux, M.
    Oszlacs, O.
    Santha, P.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 155 (08) : 1139 - 1141
  • [8] Trisubstituted pyrimidines as transient receptor potential vanilloid 1 (TRPV1) antagonists with improved solubility
    Wang, Xianghong
    Chakrabarti, Partha P.
    Ognyanov, Vassil I.
    Pettus, Liping H.
    Tamir, Rami
    Tan, Helming
    Tang, Phi
    Treanor, James J. S.
    Gavva, Narender R.
    Norman, Mark H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (23) : 6539 - 6545
  • [9] Design and synthesis of peripherally restricted transient receptor potential vanilloid 1 (TRPV1) antagonists
    Tamayo, Nuria
    Liao, Hongyu
    Stec, Markian M.
    Wang, Xianghong
    Chakrabarti, Partha
    Retz, Dan
    Doherty, Elizabeth M.
    Surapaneni, Sekhar
    Tamir, Rami
    Bannon, Anthony W.
    Gavva, Narender R.
    Norman, Mark H.
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (09) : 2744 - 2757
  • [10] Optimized flow cytometric detection of transient receptor potential vanilloid-1 (TRPV1) in human hematological malignancies
    Sofia A. Omari
    Dominic P. Geraghty
    Alhossain A. Khalafallah
    Pooja Venkat
    Yvette M. Shegog
    Scott J. Ragg
    Charles E. de Bock
    Murray J. Adams
    Medical Oncology, 39